5-APB
Systematic (IUPAC) name | |
---|---|
5-(2-aminopropyl)benzofuran | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | Uncontrolled |
Identifiers | |
CAS number | 286834-80-8 |
ATC code | None |
PubChem | CID 9837232 |
ChemSpider | 8012953 |
Chemical data | |
Formula | C11H13NO |
Mol. mass | 175.23 g/mol |
| |
| |
(what is this?) (verify) | |
5-(2-aminopropyl)benzofuran or 1-benzofuran-5-ylpropan-2-amine (5-APB) is a triple monoamine reuptake inhibitor with Ki values of 180, 265 and 811 for NET, DAT and SERT respectively as well as being a potent agonist for the 5-HT2B receptor (Ki 14nM).[1] This agonism for 5-HT2B makes it likely that 5-APB would be cardiotoxic with long term use, as seen in other 5-HT2B agonists such as fenfluramine and MDMA. The subjective effects and structure-activity relationship suggest that 5-APB is also a monoamine releasing agent. Preliminary evidence suggests 5-APB is an inhibitor of the CYP2D6 enzyme.[2]
5-APB is commonly found as the succinate and hydrochloride salt. The hydrochloride salt is 10% more potent by mass and doses should be adjusted accordingly.
5-APB is also an agonist of the 5-HT2C receptor [3] as well as a triple monoamine reuptake inhibitor.[1] It has been sold as a designer drug since 2010.[4] Anecdotal reports from users suggest it has stimulant and empathogenic effects, but less psychedelic action than related compounds such as 6-APB and 5-APDB.[citation needed]
Detection
A forensic standard of 5-APB is available, and the compound has been posted on the Forendex website of potential drugs of abuse.[5] The US Department of Justice and DEA have also conducted studies concerning the detection of 5-APB.[6]
Effects
Users describe effects as euphoric. Largely, effects reported were similar to that of the drug MDA but not as strong.
See also
- 5-MAPB
- 5-EAPB
- 5-API
- Ethylenedioxymethamphetamine
- Indanylaminopropane
- Naphthylaminopropane
- Tetralinylaminopropane
References
- ↑ 1.0 1.1 Iversen, L.; Gibbons, S.; Treble, R.; Setola, V.; Huang, X. P.; Roth, B. L. (2012). "Neurochemical profiles of some novel psychoactive substances". European Journal of Pharmacology. doi:10.1016/j.ejphar.2012.12.006.
- ↑ "Inhibition of CYP2D6 by 5-APB". Retrieved 19 November 2013.
- ↑ US patent 7045545, Karin Briner et al, "Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists", published 2000-01-19, issued 2006-16-03
- ↑ EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA
- ↑ Southern Association of Forensic Scientists, http://forendex.southernforensic.org/index.php/detail/index/1135
- ↑ USDOJ/DEA, http://www.justice.gov/dea/pr/microgram-journals/2011/mj8-2_62-74.pdf
|